These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16899405)

  • 1. Anti-MRSA beta-lactams in development.
    Page MG
    Curr Opin Pharmacol; 2006 Oct; 6(5):480-5. PubMed ID: 16899405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-lactams against methicillin-resistant Staphylococcus aureus.
    Guignard B; Entenza JM; Moreillon P
    Curr Opin Pharmacol; 2005 Oct; 5(5):479-89. PubMed ID: 16095969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can beta-lactams be re-engineered to beat MRSA?
    Livermore DM
    Clin Microbiol Infect; 2006 Apr; 12 Suppl 2():11-6. PubMed ID: 16524423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
    Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
    Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftobiprole Medocaril: BAL5788, JNJ 30982081, JNJ30982081, RO 65-5788, RO 655788.
    Drugs R D; 2006; 7(5):305-11. PubMed ID: 16922591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection.
    Parish D; Scheinfeld N
    Curr Opin Investig Drugs; 2008 Feb; 9(2):201-9. PubMed ID: 18246523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5,6-Cis-penems: broad-spectrum anti-methicillin-resistant Staphylococcus aureus beta-lactam antibiotics.
    Ishiguro M; Tanaka R; Namikawa K; Nasu T; Inoue H; Nakatsuka T; Oyama Y; Imajo S
    J Med Chem; 1997 Jul; 40(14):2126-32. PubMed ID: 9216830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftobiprole medocaril: a new generation beta-lactam.
    Del Pozo JL; Patel R
    Drugs Today (Barc); 2008 Nov; 44(11):801-25. PubMed ID: 19180259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO; Hall RG
    Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress toward the clinical development of new anti-MRSA antibiotics.
    Long TE
    IDrugs; 2003 Apr; 6(4):351-9. PubMed ID: 12789606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftobiprole: a new broad spectrum cephalosporin.
    El Solh A
    Expert Opin Pharmacother; 2009 Jul; 10(10):1675-86. PubMed ID: 19527192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel cephalosporins for the treatment of MRSA infections.
    Glinka TW
    Curr Opin Investig Drugs; 2002 Feb; 3(2):206-17. PubMed ID: 12020048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New molecules from old classes: revisiting the development of beta-lactams.
    Page MG; Heim J
    IDrugs; 2009 Sep; 12(9):561-5. PubMed ID: 19697275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
    Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the positional attachment of glycopeptide/beta-lactam heterodimers.
    Long DD; Aggen JB; Chinn J; Choi SK; Christensen BG; Fatheree PR; Green D; Hegde SS; Judice JK; Kaniga K; Krause KM; Leadbetter M; Linsell MS; Marquess DG; Moran EJ; Nodwell MB; Pace JL; Trapp SG; Turner SD
    J Antibiot (Tokyo); 2008 Oct; 61(10):603-14. PubMed ID: 19168974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of antibacterial activity of beta-lactam antibiotics by [P2W18O62]6-, [SiMo12O40]4-, and [PTi2W10O40]7- against methicillin-resistant and vancomycin-resistant Staphylococcus aureus.
    Inoue M; Suzuki T; Fujita Y; Oda M; Matsumoto N; Yamase T
    J Inorg Biochem; 2006 Jul; 100(7):1225-33. PubMed ID: 16563513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
    Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-MRSA beta-lactams in development, with a focus on ceftobiprole: the first anti-MRSA beta-lactam to demonstrate clinical efficacy.
    Bush K; Heep M; Macielag MJ; Noel GJ
    Expert Opin Investig Drugs; 2007 Apr; 16(4):419-29. PubMed ID: 17371191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mini review: a factor enhanced the antibacterial effect of beta-lactams on methicillin-resistant Staphylococcus aureus].
    Tajima Y
    Rinsho Byori; 1996 Nov; 44(11):1093-9. PubMed ID: 8953942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.